DV
Dividend Vision

FULC — Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc (FULC)

Total return is -72.3% over the past 7.1 years, 260.0 points behind SPY at 187.7%. Its deepest 1-year drawdown was 78.5%.

FULC is an equity stock focused on Fulcrum Therapeutics Inc, a company operating in the therapeutic/pharmaceutical sector. As a single-stock holding rather than a diversified fund, it does not generate dividend distributions and carries no reported expense ratio typical of traditional ETFs. This instrument appeals primarily to investors seeking direct exposure to a specific therapeutic company's equity performance rather than income-focused portfolios.

FULC key facts

Asset type
Stock
Asset class
Equity
Inception date
07/18/2019
Last close
$3.74
Market cap
$243,211,632
Average volume
980400.0
Beta
2.997
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.15